We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Consistent with previous practice, the TGA consulted with thirteen industry representative groups in December 2019 through a series of bilateral meetings:
- Medicines Australia;
- Generic and Biosimilar Medicines Association;
- AusBiotech;
- Medical Technology Association of Australia;
- Pathology Technology Australia;
- Australian Dental Industry Association;
- Australian Self Medication Industry;
- Complementary Medicines Australia;
- Accord Australasia;
- Optical Distributors & Manufacturers Association of Australia[4];
- Assistive Technology Suppliers Australasia;
- Australian Medical Device Distribution Association; and
- MTP Connect.
In order to obtain broader feedback from industry and other stakeholders, the TGA undertook a public consultation of its fees and charges through its website, which ended on 28 February 2020.
The majority of the industry bodies indicated their support for the increase to fees and charges by the indexation factor at the bilateral meetings and six industry bodies took the opportunity to present their industry view in the public consultation. Eight submissions were received through the public consultation - six from industry bodies and two from sponsors of therapeutic goods. Three of the submissions from industry bodies confirmed their support to increase the fees and charges by 1.95%. One peak body supported the indexation-based increase at the bilateral meeting in December 2019, however later requested that the Government not apply any increase because of the likely impact of the COVID-19 pandemic on business and the economy.
Two industry bodies in the medical devices sector were not supportive of the increase to TGA's fees and charges due to the increasing costs of doing business and inability to pass on such costs to their customers to remain competitive in the market. A not-for-profit organisation sponsoring clinical trials, did not support the increase in fees and requested to abolish fee increases for not for profit academic organisations.
The feedback from the submissions was put forward to Government for consideration along with the proposed fees and charges for 2020-21.Feedback was taken into account and with a view to minimise impact on industry only indexation increase of 1.95% in fees and charges was approved despite more than 4% increase in expenses in 2020-21.
Footnotes
[4] | Optical Distributors & Manufacturers Association of Australia couldn't attend this year's bilateral meeting. Therefore, the bilateral meeting presentations were provided to them for their feedback. |
---|